![](https://investorshub.advfn.com/uicon/48355.png?cb=1551739062)
Monday, December 14, 2020 9:19:37 AM
New York Yankees and Duke Basketball
Recent ARVN News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 11:33:09 AM
- Arvinas Reports Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 07/30/2024 11:00:00 AM
- HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200 • GlobeNewswire Inc. • 07/22/2024 12:30:00 PM
- Arvinas Appoints Andrew Saik as Chief Financial Officer and Treasurer • GlobeNewswire Inc. • 06/24/2024 08:37:13 PM
- Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and LRRK2 • GlobeNewswire Inc. • 06/21/2024 11:00:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 09:53:30 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 09:51:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:55:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 11:03:14 AM
- Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angela Cacace, Ph.D. to Chief Scientific Officer • GlobeNewswire Inc. • 06/17/2024 11:00:03 AM
- Arvinas to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 06/03/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 09:52:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:52:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 01:48:00 AM
- Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Congress • GlobeNewswire Inc. • 05/23/2024 09:00:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 10:05:26 AM
- Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®) • GlobeNewswire Inc. • 05/16/2024 10:00:45 AM
- Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress • GlobeNewswire Inc. • 05/09/2024 08:42:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:13:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 11:02:45 AM
- Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/07/2024 11:00:11 AM
- Arvinas to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer • GlobeNewswire Inc. • 04/24/2024 08:30:38 PM
- Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer • GlobeNewswire Inc. • 04/11/2024 11:00:49 AM
- Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer • GlobeNewswire Inc. • 03/18/2024 08:40:46 PM
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM